1. Home
  2. NINE vs QTTB Comparison

NINE vs QTTB Comparison

Compare NINE & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NINE
  • QTTB
  • Stock Information
  • Founded
  • NINE 2011
  • QTTB 2015
  • Country
  • NINE United States
  • QTTB United States
  • Employees
  • NINE N/A
  • QTTB N/A
  • Industry
  • NINE Oilfield Services/Equipment
  • QTTB Biotechnology: Pharmaceutical Preparations
  • Sector
  • NINE Energy
  • QTTB Health Care
  • Exchange
  • NINE Nasdaq
  • QTTB Nasdaq
  • Market Cap
  • NINE 28.0M
  • QTTB 23.3M
  • IPO Year
  • NINE 2018
  • QTTB N/A
  • Fundamental
  • Price
  • NINE $0.64
  • QTTB $2.27
  • Analyst Decision
  • NINE
  • QTTB Hold
  • Analyst Count
  • NINE 0
  • QTTB 7
  • Target Price
  • NINE N/A
  • QTTB $12.17
  • AVG Volume (30 Days)
  • NINE 570.6K
  • QTTB 66.6K
  • Earning Date
  • NINE 10-30-2025
  • QTTB 11-06-2025
  • Dividend Yield
  • NINE N/A
  • QTTB N/A
  • EPS Growth
  • NINE N/A
  • QTTB N/A
  • EPS
  • NINE N/A
  • QTTB N/A
  • Revenue
  • NINE $577,300,000.00
  • QTTB N/A
  • Revenue This Year
  • NINE $4.56
  • QTTB N/A
  • Revenue Next Year
  • NINE $1.41
  • QTTB N/A
  • P/E Ratio
  • NINE N/A
  • QTTB N/A
  • Revenue Growth
  • NINE 3.23
  • QTTB N/A
  • 52 Week Low
  • NINE $0.44
  • QTTB $1.35
  • 52 Week High
  • NINE $1.87
  • QTTB $53.17
  • Technical
  • Relative Strength Index (RSI)
  • NINE 44.22
  • QTTB 68.43
  • Support Level
  • NINE $0.62
  • QTTB $1.79
  • Resistance Level
  • NINE $0.68
  • QTTB $2.11
  • Average True Range (ATR)
  • NINE 0.04
  • QTTB 0.14
  • MACD
  • NINE -0.00
  • QTTB 0.04
  • Stochastic Oscillator
  • NINE 16.62
  • QTTB 78.79

About NINE Nine Energy Service Inc.

Nine Energy Service Inc is a North American onshore completion and production services provider. It targets unconventional oil and gas resource development. It operates in one segment, Completion Solutions. The Completion Solutions segment offers cementing services; completion tools, including liner hangers and accessories, frac sleeves, fully composite frac plugs, and specialty open hole float equipment and centralizers and other services. It operates in the U.S, Canada, and other countries where majority of the revenue is generated from the United States.

About QTTB Q32 Bio Inc. Common Stock

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

Share on Social Networks: